The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer

BACKGROUND Depression screening in patients with cancer is recommended by major clinical guidelines, although the evidence on individual screening tools is limited for this population. Here, the authors assess and compare the diagnostic accuracy of 2 established screening instruments: the depression...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hartung, Tim J. (VerfasserIn) , Keller, Monika (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 27 June 2017
In: Cancer
Year: 2017, Jahrgang: 123, Heft: 21, Pages: 4236-4243
ISSN:1097-0142
DOI:10.1002/cncr.30846
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1002/cncr.30846
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.30846
Volltext
Verfasserangaben:Tim J. Hartung, MA, Michael Friedrich, MA, Christoffer Johansen, MD, PhD, Hans‐Ulrich Wittchen, PhD, Herman Faller, MD, PhD, Uwe Koch, MD, PhD, Elmar Brähler, PhD, Martin Härter, MD, PhD, Monika Keller, MD, Holger Schulz, PhD, Karl Wegscheider, PhD, Joachim Weis, PhD, and Anja Mehnert, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1580476910
003 DE-627
005 20220814234229.0
007 cr uuu---uuuuu
008 180828s2017 xx |||||o 00| ||eng c
024 7 |a 10.1002/cncr.30846  |2 doi 
035 |a (DE-627)1580476910 
035 |a (DE-576)510476910 
035 |a (DE-599)BSZ510476910 
035 |a (OCoLC)1341017714 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hartung, Tim J.  |d 1989-  |e VerfasserIn  |0 (DE-588)1165615738  |0 (DE-627)1029684030  |0 (DE-576)510476074  |4 aut 
245 1 4 |a The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer  |c Tim J. Hartung, MA, Michael Friedrich, MA, Christoffer Johansen, MD, PhD, Hans‐Ulrich Wittchen, PhD, Herman Faller, MD, PhD, Uwe Koch, MD, PhD, Elmar Brähler, PhD, Martin Härter, MD, PhD, Monika Keller, MD, Holger Schulz, PhD, Karl Wegscheider, PhD, Joachim Weis, PhD, and Anja Mehnert, PhD 
264 1 |c 27 June 2017 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.08.2018 
520 |a BACKGROUND Depression screening in patients with cancer is recommended by major clinical guidelines, although the evidence on individual screening tools is limited for this population. Here, the authors assess and compare the diagnostic accuracy of 2 established screening instruments: the depression modules of the 9-item Patient Health Questionnaire (PHQ-9) and the Hospital Anxiety and Depression Scale (HADS-D), in a representative sample of patients with cancer. METHODS This multicenter study was conducted with a proportional, stratified, random sample of 2141 patients with cancer across all major tumor sites and treatment settings. The PHQ-9 and HADS-D were assessed and compared in terms of diagnostic accuracy and receiver operating characteristic (ROC) curves for Diagnostic and Statistical Manual of Mental Disorders, 4th edition diagnosis of major depressive disorder using the Composite International Diagnostic Interview for Oncology as the criterion standard. RESULTS The diagnostic accuracy of the PHQ-9 and HADS-D was fair for diagnosing major depressive disorder, with areas under the ROC curves of 0.78 (95% confidence interval, 0.76-0.79) and 0.75 (95% confidence interval, 0.74-0.77), respectively. The 2 questionnaires did not differ significantly in their areas under the ROC curves (P = .15). The PHQ-9 with a cutoff score ≥7 had the best screening performance, with a sensitivity of 83% (95% confidence interval, 78%-89%) and a specificity of 61% (95% confidence interval, 59%-63%). The American Society of Clinical Oncology guideline screening algorithm had a sensitivity of 44% (95% confidence interval, 36%-51%) and a specificity of 84% (95% confidence interval, 83%-85%). CONCLUSIONS In patients with cancer, the screening performance of both the PHQ-9 and the HADS-D was limited compared with a standardized diagnostic interview. Costs and benefits of routinely screening all patients with cancer should be weighed carefully. Cancer 2017;123:4236-4243. © 2017 American Cancer Society. 
650 4 |a depressive disorder 
650 4 |a medical psychology 
650 4 |a neoplasms 
650 4 |a receiver operating characteristic (ROC) curve 
650 4 |a sensitivity 
650 4 |a specificity 
700 1 |a Keller, Monika  |e VerfasserIn  |0 (DE-588)1067877975  |0 (DE-627)819322253  |0 (DE-576)427031575  |4 aut 
773 0 8 |i Enthalten in  |t Cancer  |d New York, NY : Wiley-Liss, 1948  |g 123(2017), 21, Seite 4236-4243  |h Online-Ressource  |w (DE-627)271350334  |w (DE-600)1479932-7  |w (DE-576)078590884  |x 1097-0142  |7 nnas  |a The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer 
773 1 8 |g volume:123  |g year:2017  |g number:21  |g pages:4236-4243  |g extent:8  |a The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer 
856 4 0 |u http://dx.doi.org/10.1002/cncr.30846  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.30846  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180828 
993 |a Article 
994 |a 2017 
998 |g 1067877975  |a Keller, Monika  |m 1067877975:Keller, Monika  |d 910000  |d 910600  |e 910000PK1067877975  |e 910600PK1067877975  |k 0/910000/  |k 1/910000/910600/  |p 9 
999 |a KXP-PPN1580476910  |e 3024087397 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"8 S."}],"relHost":[{"title":[{"subtitle":"interdisciplinary international journal of the American Cancer Society","title":"Cancer","title_sort":"Cancer"}],"disp":"The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancerCancer","note":["Gesehen am 06.12.2011"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"271350334","language":["eng"],"pubHistory":["1.1948 -"],"part":{"volume":"123","text":"123(2017), 21, Seite 4236-4243","extent":"8","year":"2017","pages":"4236-4243","issue":"21"},"titleAlt":[{"title":"Cancer cytopathology"}],"origin":[{"dateIssuedDisp":"1948-","dateIssuedKey":"1948","publisher":"Wiley-Liss","publisherPlace":"New York, NY"}],"id":{"zdb":["1479932-7"],"eki":["271350334"],"doi":["10.1002/(ISSN)1097-0142"],"issn":["1097-0142"]},"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedDisp":"27 June 2017","dateIssuedKey":"2017"}],"id":{"eki":["1580476910"],"doi":["10.1002/cncr.30846"]},"name":{"displayForm":["Tim J. Hartung, MA, Michael Friedrich, MA, Christoffer Johansen, MD, PhD, Hans‐Ulrich Wittchen, PhD, Herman Faller, MD, PhD, Uwe Koch, MD, PhD, Elmar Brähler, PhD, Martin Härter, MD, PhD, Monika Keller, MD, Holger Schulz, PhD, Karl Wegscheider, PhD, Joachim Weis, PhD, and Anja Mehnert, PhD"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 28.08.2018"],"recId":"1580476910","language":["eng"],"title":[{"title_sort":"Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer","title":"The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer"}],"person":[{"given":"Tim J.","family":"Hartung","role":"aut","roleDisplay":"VerfasserIn","display":"Hartung, Tim J."},{"family":"Keller","given":"Monika","display":"Keller, Monika","roleDisplay":"VerfasserIn","role":"aut"}]} 
SRT |a HARTUNGTIMHOSPITALAN2720